基本信息
views: 407

Bio
致力于研究功能与癌病变的分子细胞生物学机理和治疗药物及技术,运用基因/RNA、抗体/多肽、干细胞及其与纳米技术交叉融合的手段,主攻若干肿瘤(宫颈癌、肝癌)等重大健康问题的治疗药物和技术及其分子细胞机制。聚焦下列研究方向和技术手段:
1) 肿瘤等重大疾病的分子与细胞生物学机理;
2) 基因、RNA治疗和疫苗;
3) 多肽、抗体免疫治疗;
4) 正常与肿瘤干细胞治疗;
5) 纳米医药和技术及其与上述的交叉融合;
同时,与深圳国家兰科中心合作,以兰花为模式开展植物繁育与进化生物学和基因组转录组研究
1) 肿瘤等重大疾病的分子与细胞生物学机理;
2) 基因、RNA治疗和疫苗;
3) 多肽、抗体免疫治疗;
4) 正常与肿瘤干细胞治疗;
5) 纳米医药和技术及其与上述的交叉融合;
同时,与深圳国家兰科中心合作,以兰花为模式开展植物繁育与进化生物学和基因组转录组研究
Research Interests
Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jing Li, Xi Shen,Chunhui Sun,Yibo Hou, Ya Hu,Shaohua Ma,Laiqiang Huang,Lan Ma,Yubo Zhang,Xiaoyong Dai
Phytomedicine (2024): 155745-155745
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHno. 1 (2024)
CHINESE JOURNAL OF CHEMISTRYno. 1 (2024): 35-42
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 16 (2023)
Xuejiao Han,Yingtao Zhong,Chao Mi,Zhiguo He,Jingsi Gu,Xiaoyong Dai, Chenguang Ma,Chunyan Feng,Huaqing Chen, Zebin Lan,Zhiyong Guo,Laiqiang Huang,Baozhu Zhang,Bing Guo,Qingwei Meng
Theranosticsno. 7 (2023): 2176-2191
Liang Ma,Ke-Wei Liu,Zhen Li,Yu-Yun Hsiao,Yiying Qi,Tao Fu,Guang-Da Tang,Diyang Zhang,Wei-Hong Sun,Ding-Kun Liu,Yuanyuan Li,Gui-Zhen Chen,Xue-Die Liu,Xing-Yu Liao,Yu-Ting Jiang,Xia Yu,Yang Hao,Jie Huang,Xue-Wei Zhao,Shijie Ke,You-Yi Chen,Wan-Lin Wu,Jui-Ling Hsu,Yu-Fu Lin,Ming-Der Huang,Chia-Ying Li,Laiqiang Huang,Zhi-Wen Wang,Xiang Zhao,Wen-Ying Zhong,Dong-Hui Peng,Sagheer Ahmad,Siren Lan,Ji-Sen Zhang,Wen-Chieh Tsai,Yves Van de Peer,Zhong-Jian Liu
Load More
Author Statistics
#Papers: 147
#Citation: 6401
H-Index: 39
G-Index: 77
Sociability: 6
Diversity: 4
Activity: 61
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn